3 Big Pharmas That Could be Winners for Investors in the Long Run Post author:Sam Post published:November 29, 2017 Post category:BioPharma Big pharma stocks have been longtime favorites among investors for several reasons. Source: BioSpace You Might Also Like Agios, Celgene Win Early FDA Approval for New Cancer Drug July 31, 2017 Ballsy Celgene Continues to Tread Carefully Into Neurosciences January 25, 2018 BrainLAB AG Snags FDA Win for Two New Indication-Specific Radiosurgery Software Applications September 20, 2017
BrainLAB AG Snags FDA Win for Two New Indication-Specific Radiosurgery Software Applications September 20, 2017
